Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: Can we improve epidermal growth factor receptor and phospho-AKT testing? [4]

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)910
Number of pages1
JournalJournal of Clinical Oncology
Volume25
Issue number7
DOIs
Publication statusPublished - Mar 1 2007

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

@article{8bdf2f0434df43b7ad53755248b2aebe,
title = "Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: Can we improve epidermal growth factor receptor and phospho-AKT testing? [4]",
author = "Nicola Personeni",
year = "2007",
month = "3",
day = "1",
doi = "10.1200/JCO.2006.09.8137",
language = "English",
volume = "25",
pages = "910",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Outcome prediction to erlotinib in gastroesophageal adenocarcinomas

T2 - Can we improve epidermal growth factor receptor and phospho-AKT testing? [4]

AU - Personeni, Nicola

PY - 2007/3/1

Y1 - 2007/3/1

UR - http://www.scopus.com/inward/record.url?scp=33947515663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947515663&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.09.8137

DO - 10.1200/JCO.2006.09.8137

M3 - Article

C2 - 17327617

AN - SCOPUS:33947515663

VL - 25

SP - 910

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 7

ER -